Giusy Tiseo

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Combination Therapy

Multidrug Resistant

Oxide Nanoparticles

Top Venues

JAC-antimicrobial resistance

Open forum infectious diseases

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Falcone, Giusy Tiseo
Fosfomycin as a Potential Therapeutic Option in Nonsevere Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales: Need for Evidence. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Kamilia Abdelraouf, Christian M Gill, Matthew Gethers, Giusy Tiseo, Simona Barnini, Marco Falcone, Francesco Menichetti, David P Nicolau
Deciphering the Efficacy of β-Lactams in the Face of Metallo-β-Lactamase-Derived Resistance in Enterobacterales: Supraphysiologic Zinc in the Broth Is the Culprit. Open forum infectious diseases 11 (5) (2024)
Ryan K Shields, Ava J Dorazio, Giusy Tiseo, Kevin M Squires, Alessandro Leonildi, Cesira Giordano, Ellen G Kline, Simona Barnini, Alina Iovleva, Marissa P Griffith, Daria Van Tyne, Yohei Doi, Marco Falcone
Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections. JAC-antimicrobial resistance 6 (5) (2024)
Kamilia Abdelraouf, Christian M Gill, Matthew Gethers, Giusy Tiseo, Simona Barnini, Marco Falcone, Francesco Menichetti, David P Nicolau
Deciphering the Efficacy of β-Lactams in the Face of Metallo-β-Lactamase-Derived Resistance in Enterobacterales: Supraphysiologic Zinc in the Broth Is the Culprit. Open forum infectious diseases 11 (5) (2024)
Giusy Tiseo, Valentina Galfo, Niccolò Riccardi, Lorenzo Roberto Suardi, Manuela Pogliaghi, Cesira Giordano, Alessandro Leonildi, Simona Barnini, Marco Falcone
Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2024)
Giusy Tiseo, Lorenzo Roberto Suardi, Alessandro Leonildi, Cesira Giordano, Simona Barnini, Marco Falcone
Meropenem/vaborbactam plus aztreonam for the treatment of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae infections. The Journal of antimicrobial chemotherapy (2023)
Giusy Tiseo, Cesira Giordano, Alessandro Leonildi, Niccolò Riccardi, Valentina Galfo, Federica Limongi, Manuela Nicastro, Simona Barnini, Marco Falcone
Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization. JAC-antimicrobial resistance 5 (3) (2023)
Marco Falcone, Cesira Giordano, Alessandro Leonildi, Valentina Galfo, Aurelio Lepore, Lorenzo Roberto Suardi, Niccolò Riccardi, Simona Barnini, Giusy Tiseo
Clinical features and outcomes of infections caused by metallo-β-lactamases producing Enterobacterales: a 3-year prospective study from an endemic area. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, Valentina Galfo, Sara Occhineri, Stefano Verdenelli, Giancarlo Ceccarelli, Melita Poli, Marco Merli, Davide Bavaro, Anna Carretta, Giuseppe Nunnari, Emmanuele Venanzi Rullo, Enrico Maria Trecarichi, Chiara Papalini, Antonina Franco, Rosa Fontana Del Vecchio, Vincenzo Bianco, Rodolfo Punzi, Daniela Francisci, Raffaella Rubino, Carlo Torti, Massimo Puoti, Sergio Carbonara, Antonio Cascio, Annalisa Saracino, Teresa Santantonio, Mario Venditti, Francesco Menichetti
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study). JAC-antimicrobial resistance 4 (3) (2022)
Bruno Cacopardo, Dario Cattaneo, Francesco Cortese, Mariagrazia Di Luca, Marco Falcone, Giulia Carla Marchetti, Carlo Tascini, Giusy Tiseo, Mario Venditti
Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios. Expert review of anti-infective therapy 20 (7) (2022)
Marco Falcone, Giusy Tiseo
Reply to Epling and Powers, "Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients". Antimicrobial agents and chemotherapy 66 (8) (2022)
Giusy Tiseo, Lorenzo Roberto Suardi, Lisa Giusti, Arianna Forniti, Claudio Caroselli, Valentina Galfo, Sara Occhineri, Alessandro Leonildi, Giovanna Moscato, Francesco Menichetti, Marco Falcone
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study. Respirology (Carlton, Vic.) 27 (11) (2022)